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Biofilms are surface-attached communities of bacterial cells embedded in a self-
produced matrix that are found ubiquitously in nature. The biofilm matrix is composed
of various extracellular polymeric substances, which confer advantages to the
encapsulated bacteria by protecting them from eradication. The matrix composition
varies between species and is dependent on the environmental niche that the
bacteria inhabit. Exopolysaccharides (EPS) play a variety of important roles in biofilm
formation in numerous bacterial species. The ability of bacteria to thrive in a broad
range of environmental settings is reflected in part by the structural diversity of
the EPS produced both within individual bacterial strains as well as by different
species. This variability is achieved through polymerization of distinct sugar moieties
into homo- or hetero-polymers, as well as post-polymerization modification of the
polysaccharide. Specific enzymes that are unique to the production of each polymer
can transfer or remove non-carbohydrate moieties, or in other cases, epimerize
the sugar units. These modifications alter the physicochemical properties of the
polymer, which in turn can affect bacterial pathogenicity, virulence, and environmental
adaptability. Herein, we review the diversity of modifications that the EPS alginate,
the Pel polysaccharide, Vibrio polysaccharide, cepacian, glycosaminoglycans, and
poly-N-acetyl-glucosamine undergo during biosynthesis. These are EPS produced
by human pathogenic bacteria for which studies have begun to unravel the effect
modifications have on their physicochemical and biological properties. The biological
advantages these polymer modifications confer to the bacteria that produce them will
be discussed. The expanding list of identified modifications will allow future efforts
to focus on linking these modifications to specific biosynthetic genes and biofilm
phenotypes.
Keywords: Biofilm, exopolysaccharide, PNAG, PIA, alginate, PEL, VPS, cepacian
Abbreviations: Bcc, Burkholderia cepacia complex; CF, cystic ﬁbrosis; CPS, capsular polysaccharide; EPS, exopolysaccharide;
G-blocks, guluronate blocks; GAGs, glycosaminoglycans; GBS, Group B Streptococcus; GlcA, glucuronic acid; GulA,
guluronate; GulNAcA, N-acetyl guluronate; HS, heparan sulfate; IdoA, iduronic acid; LPS, lipopolysaccharide;
M-blocks, mannuronate blocks; ManA, mannuronate; MBOAT, membrane-bound O-acetyltransferase; MG-blocks, mixed
mannuronate and guluronate blocks; PEL, pel polysaccharide; PIA, polysaccharide intercellular adhesin; PNAG, poly-N-
acetylglucosamine; polyM, polymannuronate; ROS, reactive oxygen species; VPS,Vibrio polysaccharide.
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Introduction
Bacteria faced with ﬂuctuating or stressful environmental
conditions can undergo a number of physiological changes. One
common tactic that bacteria use to adapt to their surroundings
is to grow as a multicellular community or bioﬁlm. Bioﬁlm
formation begins with attachment of the bacteria to a surface
or, in the case of some infectious bioﬁlms, embedding of the
bacteria in host-derived tissue or mucous. This is followed by
bacterial aggregation, colony development, and the secretion
of self-produced polymeric substances, which form a matrix
that encapsulates and protects the bacteria (Ohman, 1986;
Allesen-Holm et al., 2006). This matrix is composed of nucleic
acids, proteins, lipids, and extracellular polysaccharides (EPS;
Flemming andWingender, 2010), with the types and ratio of each
component varying between bacterial species and environmental
conditions. Once the bioﬁlm has matured into a robust structure
it becomes exceedingly diﬃcult to eradicate, and is typically
capable of enduring mechanical, biological, and chemical means
of elimination. Bacteria form bioﬁlms in nearly all environments
studied to date (Bjarnsholt et al., 2013b), and are implicated
in the contamination of surfaces as diverse as the International
Space Station (Kim et al., 2013), ship hulls (Schultz et al., 2011),
and oil storage and transfer infrastructure (Lenhart et al., 2014).
Bioﬁlms are also of major concern in medical settings, where
they are responsible for the chronic infection of burn wounds,
eye and skin lacerations, and pneumonia in CF patients (Lyczak
et al., 2000). The contamination of medical devices such as
catheters, prosthetic joints, and ventilators (Veerachamy et al.,
2014) has also been well documented. In these environments EPS
often contribute to the formation, growth, and preservation of
bioﬁlm architecture and also serve to protect the bacteria against
antibiotics, desiccation, and the host’s immune defenses.
Biosynthesis of EPS begins in the cytoplasm with the
generation of activated precursor sugars. These precursors
are often taken from common cellular sugar pools and are
modiﬁed for speciﬁc use in EPS biosynthesis pathways, prior
to polymerization (Figure 1). In Gram-negative bacteria, the
polymer is transported across the inner membrane to the
periplasm during synthesis; whereas in Gram-positive bacteria
the polymer is transported directly to the extracellular space.
Modiﬁcations to the polymer can occur in the cytoplasm (Atkin
et al., 2014) or the periplasm (Colvin et al., 2013; Baker et al.,
2014; Little et al., 2014b; Wolfram et al., 2014) prior to export
across the outer membrane, and in the extracellular space in both
Gram-positive and Gram-negative bacteria (Rozeboom et al.,
2008; Little et al., 2014a).
The chemical structure of EPS from diﬀerent bacterial species,
or even within the same organism, can vary greatly. Bacterial
EPS are usually composed of hexose sugars, but pentose sugars
FIGURE 1 | Generalized EPS biosynthetic platforms. Not to scale. In
Gram-negative bacteria (A) modifications to the polymer can occur in the
cytoplasm, periplasm and in the extracellular space. In Gram-positive bacteria
(B) modifications can occur in the cytoplasm and extracellular space. Polymer
biosynthetic systems are represented here as follows: activated sugars (blue
hexagons with green inverted triangles) are assembled by a polymerase (blue),
transported across the inner membrane (teal; polymerization and transport may
be coupled and performed by a single protein), and exported (purple) across the
outer membrane in Gram-negative bacteria, or exported across the cytoplasmic
membrane in Gram-positive bacteria. Modifications can be performed in any of
these cellular compartments (red). Also shown, LPS (tan circles), teichoic acids
(light purple circles), and EPS (blue hexagons).
Frontiers in Microbiology | www.frontiersin.org 2 May 2015 | Volume 6 | Article 471
Whitfield et al. Exopolysaccharide modifications
have also been identiﬁed. Rhizobium huakuii EPS contains ribose
(Hisamatsu et al., 1997), while some marine bacteria produce
EPS with xylose and ribose moieties (Kwon et al., 2002). EPS
can be homo- or hetero-polymers, and have branching side
chains (Byrd et al., 2009; Cescutti et al., 2010) or be simple
linear sugar polymers (Linker and Jones, 1966; Maira-Litràn
et al., 2002). They can be as short as dimers and trimers, or
thousands of saccharide repeat units long (González et al., 1998),
depending on the mechanisms of chain length regulation, and
can even be woven together to form ﬁbers (Benziman et al.,
1980).
Exopolysaccharides can be modiﬁed by the action of
transferases and hydrolases which add or remove functional
groups such as acetyls, pyruvyls (Marzocca et al., 1991),
glyceryls (Kuo et al., 1986), succinyls (Reuber and Walker,
1993), lactyls (Maalej et al., 2014), or a combination of these,
leading to variations in polymer surface electrostatics and
solubility. Additionally, epimerization can drastically alter the
structural conformation of polysaccharides, aﬀecting polymer
interactions within the bioﬁlm (Steigedal et al., 2008). Some
of these modiﬁcations have been studied with respect to
their importance in bacterial virulence, pathogenesis, bioﬁlm
formation, or symbiosis (Figure 2; Ridout et al., 1997), as well
as their commercial utility in the food and cosmetic industries.
Despite this wealth of knowledge, there remain a number of
unresolved questions regarding the biological implications of EPS
modiﬁcations. In this review, we explore the modiﬁcations that
bioﬁlm-forming EPS produced by human pathogenic bacteria
undergo and discuss the proteins involved in modiﬁcation, as
well as the role modiﬁcations play in bacterial persistence in the
environment and host.
FIGURE 2 | Exopolysaccharide modifications offer protection to
bacteria. Modifications to EPS contribute to evasion of host immune
mechanisms such as complement deposition (C3b), and specific antibody
production (lavender). Modifications have also been shown to protect against
ROS produced by immune cells, antimicrobial peptides, and EPS degradation
enzymes produced by competing microorganisms.
Alginate
Alginate synthesis has been characterized in several species
of brown algae, as well as in the genera Azotobacter and
Pseudomonas (Gorin and Spencer, 1966; Evans and Linker,
1973; Govan et al., 1981; Gacesa, 1988). Bacterial alginate is
a high molecular weight, linear polysaccharide composed of
β-1,4-linked D-ManA and variable amounts of its C5 epimer L-
GulA (Smidsrød and Draget, 1996). In Pseudomonas aeruginosa
and Azotobacter vinelandii, alginate is initially synthesized as
polyM in the cytoplasm and is shuttled across the inner
membrane to the periplasm, where it is randomly acetylated
at the O2 and/or O3 hydroxyl positions (Table 1; Figure 3;
Franklin and Ohman, 1993, 1996, 2002). ManA residues that
are not acetylated serve as substrates for epimerization at the
C5 position by the enzyme AlgG in the periplasm, leading to
the formation of mixed ManA and GulA segments (MG-blocks)
as well as non-epimerized sections (M-blocks; Gacesa, 1988;
Jain et al., 2003).
Pseudomonas aeruginosa chronic lung infections in CF
patients are the leading cause of morbidity andmortality. In these
infections the production of alginate is often linked to poorer
patient prognosis (Lyczak et al., 2000). In the lung, the clinical
isolate P. aeruginosa FRD1 displays an alginate-overproducing,
or mucoid phenotype due to mutations in negative regulatory
elements, providing P. aeruginosa with the capability of adhering
to respiratory tract epithelial cells and mucin (Marcus and Baker,
1985; Doig et al., 1987; Ramphal et al., 1987). In addition,
alginate production has been linked to the hindrance of host cell-
mediated phagocytosis and neutralization of ROS (Learn et al.,
1987; Mai et al., 1993; Pier et al., 2001). Mucoid conversion
is still not well understood, but in vitro experimentation has
shown that nutrient and aeration levels (Buckmire, 1984; Krieg
et al., 1986; Speert et al., 1990) and external stressors (Terry
et al., 1991; Damron et al., 2011; Limoli et al., 2014) can induce
mucoidy.
Azotobacter vinelandii is a soil-borne bacterium that is
often used as a model organism for nitrogen ﬁxation studies
(Bulen et al., 1964). Although A. vinelandii is not a human
pathogen, understanding the process of alginate biosynthesis
in this organism has provided valuable insight into the
biological signiﬁcance of alginate production by P. aeruginosa.
In A. vinelandii, alginate plays a unique and essential role where,
under conditions of nutrient and environmental stress such as
nitrogen starvation, A. vinelandii converts from a vegetative cell
to a dormant cyst (Socolofsky andWyss, 1961). Cyst development
proceeds through deposition of a protective extracellular material
composed primarily of alginate. The cyst layers are rich
in proteins, lipids and carbohydrates, with the exine (outer
layer) and intine (inner layer) containing carbohydrate material
consisting of approximately 40 and 72% polyuronic acids,
respectively (Lin and Sadoﬀ, 1969). Cyst formation, much like
the bioﬁlm matrix, protects A. vinelandii from desiccation, and
only when environmental conditions become more favorable will
A. vinelandii convert back to the vegetative state by degrading
the alginate barrier. In contrast to P. aeruginosa, A. vinelandii
contains seven additional extracellular epimerases (AlgE1-7),
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FIGURE 3 | Pseudomonal alginate modifications and biosynthetic
apparatus. Not to scale. (A) Alginate is first polymerized as β-scD-(1→4)-polyM
(top) before being acetylated at the O2 and/or O3 positions by the concerted
actions of AlgIJFX. Acetylated ManA residues (middle) cannot be epimerized to
L-GulA by AlgG (bottom). (B) The proteins involved in alginate biosynthesis in
Pseudomonas aeruginosa. PolyM (green hexagon chain) is synthesized in the
cytoplasm from the nucleotide-sugar precursor GDP-ManA (green hexagons
with inverted triangles). It is polymerized, and transported across the inner
membrane via Alg8/44, acetylated (red triangles) by the concerted action of
AlgFIJX, and epimerized to GulA (magenta) by AlgG. AlgL possesses lyase
activity; AlgK is a lipoprotein required for efficient localization of AlgE, the porin
required for alginate export.
capable of generating polyguluronate segments (G-blocks) in
addition to MG-blocks (Table 1; Fischer and Dorfel, 1955;
Haug et al., 1966, 1967). Despite the importance of alginate in
cyst formation (Campos et al., 1996), alginate production by
A. vinelandii has been studied primarily for its potential use as an
alternative source of commercial alginate in place of traditional
seaweed harvesting approaches.
Given the importance of alginate for the virulence of
P. aeruginosa in the CF lung, the protective characteristics
of A. vinelandii cysts, and the use of bacterial alginate as a
convenient substitute for commercial eukaryotic alginate sources,
there has been a drive to understand the consequences of alginate
acetylation and epimerization on these processes.
Alginate Acetylation
Alginate acetylation in P. aeruginosa requires the collective
actions of the proteins AlgF, AlgI, AlgJ, and AlgX for the
addition of acetyl groups to the O2 and/or O3 hydroxyl positions
of polyM in the periplasm prior to epimerization and export
(Table 1; Figure 3). Speciﬁcally, it is thought that AlgI transfers
an acetyl group from an as yet unidentiﬁed cytoplasmic donor
to AlgJ or AlgX, where it may be passed between them before
transfer to the polymer by AlgX (Riley et al., 2013; Baker et al.,
2014). AlgF is an important part of the acetylation process but
has not yet been assigned a role. Based on the peptidoglycan
O-acetylation machinery (Moynihan and Clarke, 2011), it seems
that the presence of a MBOAT for acetyl-donor transport
(AlgI), and an acetyltransferase (AlgX) should be suﬃcient
for polysaccharide O-acetylation. As acetylation occurs at both
the O2 and O3 positions, one hypothesis is that the proteins
AlgJ and AlgF govern speciﬁcity. Although they have not yet
been shown to directly bind alginate, they may still be able to
regulate the position and frequency of acetyl addition under
diﬀerent environmental conditions. Genetic and biochemical
experiments targeting the degree of alginate acetylation in
combination with structural data may provide insight into these
questions.
One of the purposes of EPS production is to serve as a
structural component of the bioﬁlm matrix. Alginate lacking
O-acetyl groups has been analyzed for its ability to form
structured bioﬁlms using an acetylation defective P. aeruginosa
FRD1 mutant. These studies revealed that the mutant was only
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TABLE 2 | Biological implications of EPS modifications.
Modification Proteins involved Organism studied Implication of modification Reference
Alginate
Acetylation AlgF, AlgI, AlgJ, AlgX Pseudomonas
aeruginosa
Required for surface attachment and formation of
structured microcolonies
Nivens et al. (2001), Tielen
et al. (2005)
Increased polymer viscosity Tielen et al. (2005)
Decreased neutrophil locomotion and lymphocyte
transformation
Mai et al. (1993)
Reduced activation of complement and opsonic killing
by phagocytes
Pier et al. (2001)
Scavenging of ROS Learn et al. (1987)
Reduced susceptibility to enzymatic degradation Farrell and Tipton (2012)
Increased gel thickness Skjåk-Braek et al. (1989)
Epimerization AlgG, AlgE1-7 (Azotobacter
vinelandii)
P. aeruginosa Improved gel forming ability (cohesion) Grant et al. (1973), Donati
et al. (2005)
Upregulation of virulence factors through Ca2+
sequestration
Horsman et al. (2012)
A. vinelandii Maintain biofilm structure during changing
environmental conditions
Ertesvåg et al. (1998)
Preserve N2-fixing capability Sabra et al. (2000)
Required for formation of functional cyst coat Steigedal et al. (2008)
PEL
Deacetylation PelA P. aeruginosa Required for biofilm formation (in PSL deficient strains) Colvin et al. (2013)
Cepacian
Acetylation BceOSU Bcc Reduced susceptibility to enzymatic degradation Cescutti et al. (2006)
Scavenging of ROS Cuzzi et al. (2012)
Vibrio polysaccharide (VPS)
Acetylation VpsG Vibrio cholerae Required for robust biofilm formation and wild-type
phenotypes
Fong et al. (2010)
Poly-N-acetyl-glucosamine (PNAG)
Deacetylation PgaB (Escherichia coli),
HmsF (Yersinia pestis) IcaB
(Staphylococcus epidermidis
and S. aureus)
S. epidermidis Required for biofilm formation and surface attachment Vuong et al. (2004a)
Resistance to human cationic antimicrobial peptides
Resistance to neutrophil phagocytosis
Persistence in mouse model of infection
S. aureus Required for biofilm formation and surface attachment Cerca et al. (2007)
Resistance to phagocytosis
Persistence in mouse model of infection
E. coli Required for export of polymer and biofilm formation Itoh et al. (2008)
Y. pestis Required for biofilm formation Forman et al. (2006)
Succinylation IcaC S. aureus Modulation improves in vitro fitness Brooks and Jefferson (2014)
able to produce small, unstructured microcolonies that sparsely
populated the examined surface, suggesting an attachment defect
(Table 2; Nivens et al., 2001). In contrast, FRD1 formed
extensive bioﬁlm structures that exhibited signiﬁcant structural
heterogeneity. In a separate study, an aggregation defect was
revealed when the capacity for an acetylation-deﬁcient FRD1
mutant to adhere to a steel surface was tested (Tielen et al.,
2005). Additionally, the viscosity of extracellular material from
the acetylation-defective mutant was signiﬁcantly reduced in
comparison to FRD1, suggesting that the loss of O-acetyl groups
led to weakening of inter- and intra-polymer interactions within
the bioﬁlm matrix. This is supported by rheological studies
of FRD1 bioﬁlms, which suggested that inter-chain alginate
interactions occur primarily through physical entanglements
(Wloka et al., 2005). These entanglements supported an elastic
bioﬁlm architecture, which diﬀered from O-acetylation-defective
FRD1 mutants which produced weaker bioﬁlms with reduced
resistance to tensile forces. Based on these results, it was suggested
that O-acetyl groups in alginate act as molecular hooks that
improve the resistance of the entangled alginate structural
network against applied forces (Wloka et al., 2005). While the
importance of alginate acetyl groups for cell aggregation and
microcolony formation in vitro is well established, the inﬂuence
of O-acetyl groups on bioﬁlm formation phenotypes in clinically
relevant P. aeruginosa infections or related in vivomodel systems
of infection remain uncharacterized.
P. aeruginosa bioﬁlm formation in the CF lung has been shown
to provide signiﬁcant protection from a variety of host immune
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factors. For example, decreased locomotion of neutrophils, as
well as reduced lymphocyte transformation, have been observed
when these cell types are incubated with alginate (Simpson et al.,
1988). However, chemical removal of acetyl groups from alginate
led to a complete loss of these inhibitory eﬀects on neutrophil
and lymphocyte function, suggesting that alginate O-acetylation
is essential for their suppression (Mai et al., 1993). The activation
of complement is also aﬀected by the presence of acetyl groups
(Pier et al., 2001). This is not surprising given that interactions
between alginate and the complement component C3b likely
occurs through unsubstituted hydroxyl groups (Hostetter et al.,
1982), suggesting that the addition of acetyl groups to alginate in
P. aeruginosamay have evolved as a mechanism for complement
evasion. Activation of the alternative pathway of complement can
lead to phagocytic killing, which is also impaired by the presence
of O-acetyl groups. Opsonic killing of the FRD1 O-acetylation
deﬁcient mutant by phagocytes was readily observed, while
wild-type FRD1 was resistant to these attacks (Pier et al.,
2001). Alginate is also known to scavenge ROS produced by
phagocytic cells during infection. Hypochlorite is a common ROS
produced by phagocytes, and the presence of alginate in mucoid
P. aeruginosa provides a signiﬁcant protective advantage against
hypochlorite over non-mucoid cells in vitro (Learn et al., 1987).
This protective eﬀect was, in part, attributed to the O-acetyl
groups, as chemically deacetylated alginate exhibited impaired
hypochlorite scavenging. Furthermore, addition of hypochlorite
to native alginate led to a decrease in viscosity, similar to that
seen for the chemically deacetylated alginate, suggesting that
hypochlorite may be speciﬁcally reacting with O-acetyl groups
from native alginate (Learn et al., 1987).
When bacteria are contending for control of the same
environment, they can release extracellular enzymes to degrade
critical structural components of cohabiting organisms to
give them a competitive advantage (Korotkov et al., 2012).
This is observed in the CF lung, where instances of multi-
species bioﬁlms are common (Elias and Banin, 2012). During
colonization of the CF lung, alginate acetyl groups may serve
as a protective mechanism to prevent unwanted degradation
of alginate within the bioﬁlm by bacteria that could secrete
an AlgL-like lyase as an oﬀensive tactic. The P. aeruginosa
alginate lyase AlgL preferentially degrades deacetylated alginate
or polyM over mature, acetylated alginate (Farrell and Tipton,
2012). Furthermore, O-acetyl groups prevent the epimerization
of ManA to GulA by the epimerases AlgE1-7 in A. vinelandii,
whichmay allow for control over the degree of epimerization and,
in turn, regulation of the cyst coat composition.
Alginate acetylation content ranges from 4 to 57%, depending
on the percentage of ManA present (Skjåk-Braek et al., 1986).
The degree of O-acetylation is often observed to vary not
only between diﬀerent alginate-producing organisms, but also
between diﬀerent strains of the same organism and even within
the same strain under diﬀering growth conditions (Marty et al.,
1992; Peña et al., 2006). For example, modulation of carbon
source during growth for a single alginate-producing P. syringae
strain led to signiﬁcant diﬀerences in acetyl content, ranging
from 9 to 34% of total uronic acids bearing an acetyl group
(Day, 1988). In another study, the alginate produced by several
diﬀerent strains of P. aeruginosa grown on nutritionally distinct
media was examined. This study revealed that between diﬀerent
strains O-acetyl content of alginate varied between 2 to 56%
(Marty et al., 1992). Furthermore, in both studies alginate acetyl
content changed over the course of a single growth experiment
by as much as 40%, possibly owing to the availability of
acetyl-CoA, the proposed acetyl donor (Lee and Day, 1998). In
addition to acetyl-CoA availability, diﬀerences in acetyl content
could conceivably be a means to optimize attachment, nutrient
uptake, or nutrient diﬀusion within the bioﬁlm in the face of
diﬀerent media compositions and nutrient sources. This notion is
supported by ﬁndings which suggest that alginate O-acetylation
can enhance the swelling ability of calcium alginate gels (Skjåk-
Braek et al., 1989). Deacetylated alginate exhibited poor swelling
ability in comparison to chemically acetylated variants, with
increasing degrees of acetylation leading to greater swelling
volume. Conversely, increased O-acetylation led to a decrease in
the aﬃnity of alginate gels for calcium ions (Skjåk-Braek et al.,
1989). Thus, alginate acetyl content has speciﬁc consequences
with respect to calcium ion binding and the thickness of alginate
gels, which may inﬂuence nutrient diﬀusion in the bioﬁlm. These
ﬁndings could potentially be extrapolated to other components
of the growth media, and suggests a mechanism by which
alginate-producing bacteria could regulate the uptake of essential
nutrients.
Alginate Epimerization
Pseudomonas aeruginosa has a single alginate C5-epimerase
in the periplasm, AlgG. In A. vinelandii, there is an AlgG
ortholog that performs the same function, and seven additional
extracellular epimerases, AlgE1 through AlgE7 (Table 1).
Alginate can form strong gels through interactions with
GulA residues, mediated by Ca2+ ions. This feature was
thought to be limited to alginates containing G-blocks, and
would therefore exclude the MG-block alginates produced by
P. aeruginosa (Grant et al., 1973). However, it is now thought
that alginates containing exclusively MG-blocks can also form
gels in the presence of Ca2+ (Donati et al., 2005), suggesting
that epimerization by AlgG in P. aeruginosa may serve as a
mechanism to improve the cohesion of alginate during bioﬁlm
formation. It was found that addition of CaCl2 to growth media
led to the production of bioﬁlms that were 10- to 20-fold thicker
than that produced in the absence of Ca2+ (Sarkisova et al.,
2005). Ca2+-alginate interactions also regulate virulence factor
expression, as chelation of Ca2+ by alginate induces expression
of the Type 3 secretion system (Horsman et al., 2012). Therefore,
it appears that there are mechanisms in place in P. aeruginosa for
virulence factors to be upregulated by the expression of another,
thus allowing for concerted actions that improve ﬁtness (Table 2).
Despite advances in understanding the interplay between Ca2+
and alginate in P. aeruginosa, and the extensive studies performed
on acetyl-deﬁcient alginate, there are no reports on the eﬀects of
epimerization on bioﬁlm formation, pathogenicity, or virulence.
In contrast, the role of epimerization in A. vinelandii cyst
formation has been well characterized. One hypothesis regarding
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the ability of A. vinelandii to express multiple epimerases
with unique activities is that these enzymes allow the alginate
structures to be tailored to diﬀerent layers of the cyst under
diverse environmental conditions. For example, the epimerase
AlgE1 has two catalytic domains that introduce primarily
MG-blocks and G-blocks, respectively (Ertesvåg et al., 1998).
Decreasing the availability of Ca2+ in the presence of AlgE1
in vitro led to greater incorporation of G-blocks into polyM
alginate. This may provide a means in vivo to maintain the
strength of Ca2+-mediated inter-alginate bonds in the face of
decreased environmental Ca2+ availability (Ertesvåg et al., 1998).
Regulation of alginate structure is also observed during vegetative
growth of A. vinelandii, where nitrogen ﬁxation is mediated by
the expression of highly oxygen-sensitive nitrogenases. In this
state, alginate is utilized as a barrier to prevent the diﬀusion of
oxygen into the cell. In the presence of increasing environmental
O2 concentrations, A. vinelandii was able to produce alginate
with greater G-content, which led to the formation of a thicker,
denser alginate layer around the cell and thus limited oxygen
penetration (Sabra et al., 2000). The expression of diﬀerent
mannuronan C5-epimerases is also regulated over the course
of the A. vinelandii life cycle, including during vegetative
growth, cyst development, and cyst germination (Høidal et al.,
2000). Although the exact biological function for the expression
of speciﬁc epimerases at unique points in the life cycle of
A. vinelandii has not been determined, preferential expression of
AlgE7 during cyst germination could be linked to the apparent
lyase activity of this enzyme, which may be utilized to degrade
the cyst coat (Høidal et al., 2000).
Unlike AlgG in P. aeruginosa, the importance of the AlgE1-
7 epimerases in the formation of the cyst coat and tolerance
to desiccation has been explored. Inactivation of the AlgE1-7
epimerases, either through chromosomal deletion inA. vinelandii
(Steigedal et al., 2008) or by inactivating the Type 1 secretion
system responsible for their export (Gimmestad et al., 2006)
led to the production of low G-content alginate, suggesting
that the periplasmic A. vinelandii AlgG is active but not very
eﬃcient. In both cases, these mutants were unable to form
a cyst coat and could not survive desiccation. In contrast,
deletion of individual algE genes, with the exception of algE3,
did not have an appreciable eﬀect on the G-content of alginate.
Deletion of algE3 showed a signiﬁcant reduction in G-content
(Steigedal et al., 2008). However, since each of the individual algE
deletion mutants was able to form a functional cyst and survive
desiccation, it appears that no single epimerase is absolutely
essential for cyst formation or germination. This suggests that
the presence of multiple extracellular epimerases may increase
redundancy of epimerase activity to ensure formation of a
functional cyst coat (Steigedal et al., 2008). It remains to
be determined whether cyst formation under unique stressful
conditions may require speciﬁc epimerases, and little work has
been done to date to examine the role of mannuronan C5-
epimerases during the vegetative stage of A. vinelandii growth.
While a great deal is understood about the regulation of
alginate biosynthesis and its modiﬁcation at the genetic and
protein level (Hay et al., 2014), the implications of alginate
acetylation and epimerization in terms of bioﬁlm formation,
pathogenicity and virulence, environmental adaptability and
survivability remain largely uncharacterized.
The Pel Polysaccharide
In addition to alginate, P. aeruginosa is capable of synthesizing
two other polymers that have been implicated in bioﬁlm
formation, the Pel and Psl polysaccharides (PEL and PSL;
Franklin et al., 2011). Unlike alginate, PEL and PSL are primarily
associated with the establishment of non-mucoid bioﬁlms. PSL is
a neutral, branched polysaccharide with a ﬁve-sugar repeat unit
composed of D-mannose, D-glucose, and L-rhamnose and is not
thought to undergo any modiﬁcations after polymerization (Byrd
et al., 2009). The exact structure of PEL is currently unknown, but
it is predicted to be glucose rich (Friedman and Kolter, 2004; Ma
et al., 2012). Colvin and colleagues have demonstrated that the
PEL biosynthesis protein PelA has deacetylase activity in vitro
and when residues predicted to be required for deacetylation
were mutated, this activity was lost. Introduction of these PelA
deacetylation mutations in P. aeruginosa PA14, which uses PEL
as the primary EPS, led to a bioﬁlm deﬁcient phenotype and a
lack of material recognizable by PEL-reactive antisera (Table 1;
Colvin et al., 2013). Given the localization of PelA to the
periplasm (Colvin et al., 2013), deacetylation of PEL following
polymerization may be necessary for bioﬁlm formation, and
suggests that an acetylated sugar is likely a feature of the PEL.
Our current understanding of PEL biosynthesis is limited, and
it remains to be determined whether PelA acts directly on PEL,
the degree of PEL deacetylation by PelA, and what eﬀect this
modiﬁcation has on virulence.
Cepacian
The Bcc is a group of at least 17 diﬀerent bacterial species,
including beneﬁcial environmental isolates, as well as
rhizosphere parasites, and plant and animal pathogens
(Mahenthiralingam et al., 2002; Vanlaere et al., 2009). The
Bcc have become increasingly important as opportunistic
pathogens of immunocompromised individuals and those
with CF (Mahenthiralingam et al., 2005). In CF patients, Bcc
infections occasionally develop into a form of necrotising
pneumonia, known as cepacia syndrome, which often leads to
patient death (Govan and Deretic, 1996). The majority of both
clinical and environmental Bcc isolates produce the EPS cepacian
(Ferreira et al., 2010); a known virulence factor that contributes
signiﬁcantly to bacterial pathogenicity. Cepacian is composed of
glucose, GlcA, mannose, rhamnose, and galactose in a 1:1:1:1:3
ratio and is decorated with acetyl groups (Figure 4; Cérantola
et al., 1999; Cescutti et al., 2000; Linker et al., 2001). The acetyl
groups can be found at 12 diﬀerent locations on the polymer
repeating unit with an average of three acetyl groups present
per repeat unit (Cescutti et al., 2011). The genes responsible for
cepacian acetylation were discovered by Ferreira and colleagues,
and include the putative acetyltransferases bceO, bceS, and bceU
(Ferreira et al., 2010). Mutations in bceS produced cepacian with
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FIGURE 4 | Cepacian modifications and biosynthetic apparatus. Not to
scale. (A) Cepacian may be O-acetylated at various locations by BceOSU,
leading to a number of unique combinations with an average of three acetyls per
repeat unit. (B) Cepacian repeat units are synthesized in the cytoplasm on an
isoprenoid lipid carrier (black circle/gray circle), initiated by BceB and continued
by glycosyltransferases BceGHJKR. BceGHR are cytoplasmic, while BceJK are
integral membrane proteins. BceOSU are predicted to be membrane embedded
acetyltransferases that decorate the repeat unit with acetyl groups. BceQ
translocates the repeat units across the inner membrane, followed by addition
of repeat units to the growing polymer at the periplasmic side, which is
dependent on BceI. Polymerization and export requires BceF, a tyrosine kinase.
BceD is a protein tyrosine phosphatase which dephosphorylates BceF. BceE is
the channel for polymer export across the OM. BceP is putatively involved in
polysaccharide degradation, though its role and localization is unkonwn. ATP,
adenosine-5′ -triphosphate; ADP, adenosine-5′-diphosphate; YP,
phosphorylated tyrosine residue; Pi, inorganic phosphate. Green hexagon,
galactose; orange hexagon, GlcA; light blue hexagon, mannose; maroon
hexagon, rhamnose; blue hexagon, glucose.
approximately 20% fewer acetyl groups, implicating this protein
in partial cepacian acetylation (Ferreira et al., 2010). The roles of
bceO and bceU in cepacian acetylation have not been evaluated,
nor has a triple mutant been generated to discern the ﬁtness of
an acetyl-deﬁcient cepacian producer.
An enzyme with lyase activity that speciﬁcally degrades
cepacian has been isolated from culture supernatants of
Bacillus sp. This enzyme has signiﬁcantly higher activity against
the chemically deacetylated polymer than native cepacian,
implicating acetylation in protective mechanisms (Table 2;
Cescutti et al., 2006). As with alginate acetylation, cepacian
acetylation may have evolved as a defensive mechanism to
prevent polymer cleavage in the presence of competitive
organisms. Furthermore, like alginate, cepacian acetyl groups
have been shown to provide protection against ROS, speciﬁcally
hypochlorite (Cuzzi et al., 2012). Acetyl groups were the ﬁrst
structural features to undergo damage following hypochlorite
treatment, which led to a loss of polymer-polymer interactions
and cepacian unfolding, increasing the susceptibility of the
cepacian backbone to hypochlorite degradation (Cuzzi et al.,
2012). Consequently, cepacian acetylation improves polymer
robustness to hypochlorite-mediated damage and increases
the amount of polymer reactive groups that could neutralize
hypochlorite prior to reaching the cellular surface. Further
study of cepacian producing Bcc pathogens is necessary to
determine, whether like alginate, there is a role for cepacian acetyl
modiﬁcation in immune evasion.
Vibrio Polysaccharide (VPS)
Vibrio cholerae is a human pathogen that causes the diarrhoeal
disease cholera (Kaper et al., 1995; Faruque et al., 1998). This
bacterium is a natural inhabitant of aquatic ecosystems, where
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it forms bioﬁlms on a variety of surfaces, including plankton,
plants, crustaceans, insects, and sediment (Huq et al., 1983, 1995;
Halpern et al., 2004; Broza et al., 2005). In areas where cholera
is endemic, V. cholerae has been shown to form suspended
bioﬁlm-like aggregates in surface waters, however, when particles
>20 μm in diameter are removed from water sources, the
incidence of cholera can be reduced (Huq et al., 1996; Colwell
et al., 2003). Furthermore, it has been shown that the average
infectivity of the aggregate form of V. cholerae is signiﬁcantly
higher than that of planktonic cells (Faruque et al., 2006),
and bioﬁlm formation within aquatic ecosystems signiﬁcantly
improves V. cholerae ﬁtness and persistence (Matz et al., 2005).
A major component of the bioﬁlm produced by V. cholerae is
an EPS called VPS. This polymer is thought to be produced
during infection and contributes to bacterial colonization and
survival (Yildiz and Schoolnik, 1999; Fong et al., 2010). The
chemical structure of VPS revealed a backbone containing
the unusual constituent GulNAcAGly: the amide formed from
2-acetamido-2-deoxy-L-guluronic acid and glycine (Figure 6;
Yildiz et al., 2014). Of the genes involved in VPS biosynthesis,
originally identiﬁed using a transposon mutagenesis screen
(Yildiz and Schoolnik, 1999), two putative acetyltransferases,
vpsG and vpsC, were identiﬁed (Fong et al., 2010). Deletion of
vpsG results in reduced bioﬁlm formation and altered bioﬁlm-
related phenotypes, as well as weak reactivity with VPS antisera,
suggesting that it may modify the polymer, perhaps through
acetylation (Table 1). In contrast, deletions of vpsC do not
aﬀect bioﬁlm formation or VPS production, suggesting that
vpsC is inactive, not expressed, or is performing some other
function in VPS biosynthesis besides polymermodiﬁcation (Fong
et al., 2010). The chemical composition of VPS produced by
vpsG and vpsC mutants was not studied for alterations in
acetyl content. The presence of GulNAcA in VPS may be
the result of epimerization by the predicted GDP-mannose
dehydrogenase VpsB, a conversion similar to the ManA to
GulA epimerization catalyzed by AlgG in the biosynthesis of
alginate by P. aeruginosa (Wolfram et al., 2014; Yildiz et al.,
2014). The unusual glycine modiﬁcation in VPS requires further
exploration, as the enzyme responsible for its addition is presently
unknown. Given the important role of VPS in V. cholerae
pathogenesis and environmental persistence, and the recent
determination of its precise chemical structure, we anticipate that
the proteins involved in VPS modiﬁcation will soon be identiﬁed
and characterized.
Glycosaminoglycans (GAGs)
GAGs are a group of polymers that are typically composed of
a disaccharide repeat unit containing an amino sugar and a
hexuronic acid (Laurent and Fraser, 1992; Esko and Lindahl,
2001; DeAngelis, 2002; Silbert and Sugumaran, 2002). GAGs
were initially thought to exist only in the animal kingdom, where
they serve essential biological functions, however, there has
been an emergence of GAG-like polymers amongst prokaryotes
(Vann et al., 1981; Rodriguez et al., 1988; DeAngelis et al.,
2002). Prokaryotic GAGs are typically less complex than their
eukaryotic counterparts due to an absence of modiﬁcations such
as sulfation (Raedts et al., 2011). HS, for example, is an essential
GAG in animals and is composed of repeating disaccharides
of GlcA and GlcNAc (Kjellén and Lindahl, 1991). HS can be
modiﬁed post-polymerization by a glucuronyl C5-epimerase,
which converts GlcA to IdoA, as well as by the addition of sulfate
groups to GlcNAc or IdoA moieties. Mouse embryos lacking
the GlcA C5-epimerase display a lethal phenotype characterized
by skeletal malformations and lung defects (Li et al., 2003),
highlighting the importance of HS epimerization in murine
development. Interestingly, the K5 antigen of E. coli O10:K5:H4
has an identical structure to heparosan, the unsulfated, non-
epimerized backbone structure of HS (Vann et al., 1981). K5
heparosan is a form of molecular camouﬂage, as it imparts
low immunogenicity to the bacterium in humans and hence
increased pathogenicity (Vann et al., 1981).
Although sulfation has not yet been observed amongst
prokaryotic GAGs, IdoA residues have been found to be
constituents of bacterial GAGs (Figure 6). The identiﬁcation
of the bacteria glucuronyl C5-epimerase has proven elusive
(Raedts et al., 2011), however, an enzyme (RED65_08024) from
the marine bacterium Bermanella marisrubi that shares 37%
sequence similarity with the human glucuronyl C5-epimerase
has been characterized and shown in vitro to convert GlcA
to IdoA in de-sulfated mouse HS (Raedts et al., 2013). This
glucuronyl C5-epimerase represents the ﬁrst prokaryotic protein
capable of generating IdoA residues, and is the only identiﬁed
epimerase that can function on bacterial polysaccharides post-
polymerization, besides AlgG and AlgE1-7. Unfortunately, the
EPS produced by B. marisrubi has not been characterized, so
its target remains unknown. Nevertheless, the ability of bacteria
to more closely replicate the structures of essential human
polysaccharides by expression of homologous modiﬁcation
enzymes likely serves as a mechanism to mask their presence
from the host immune system (Cress et al., 2014).
Poly-β-1,6-N-Acetyl-glucosamine
(PNAG)
Poly-β-1,6-N-acetyl-glucosamine is a poly-GlcNAc polymer
that is produced by a wide range of Gram-positive and
Gram-negative bacterial pathogens, including Staphylococcus
epidermidis, Staphylococcus aureus, Escherichia coli, Yersinia
pestis, Bordetella sp., Acinetobacter baumanii, Actinobacillus
pleuropneumoniae, Burkholderia cepacia complex (Bcc), and
Aggregatibacter actinomycetemcomitans (Cramton et al., 1999;
Vuong et al., 2004b; Wang et al., 2004; Izano et al., 2007,
2008; Parise et al., 2007; Bobrov et al., 2008; Choi et al., 2009).
These organisms are responsible for a wide spectrum of diseases,
including but not limited to, hospital acquired infections, toxic
shock syndrome, plague, and whooping cough. Depending on
the source or organism in question, PNAG may also be referred
to as PGA (polyglucosamine, in Gram-negative bacteria), PIA
(in Gram-positive bacteria), poly-NAG, hms+ (in Y. pestis),
or BPS (Bordetella polysaccharide, in Bordetella sp.). Given the
diﬀerences in PNAG modiﬁcations between Gram-positive and
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Gram-negative bacteria, as described below, we will use PGA and
PIA to refer to PNAG polymer produced by Gram-negative and
Gram-positive organisms, respectively.
Initially S. epidermidis was thought to produce several
diﬀerent polymers, but the discovery of the icaADBC operon
(Heilmann et al., 1996a,b; Gerke et al., 1998) revealed that
only a single polymer, PIA, was produced (Tojo et al., 1988;
Christensen et al., 1990; Heilmann et al., 1996a; Mack et al.,
1996; McKenney et al., 1998). PIA is a partially deacetylated
β-1,6-GlcNAc polymer. In S. epidermidis and S. aureus 15–
20% of the N-acetyls are removed by the extracellular, cell-
surface associated polysaccharide deacetylase IcaB (Table 1;
Figure 5; Vuong et al., 2004a; Cerca et al., 2007). In addition
to deacetylation, approximately 6 and 10% of GlcNAc residues
in S epidermidis and S. aureus, respectively, are O-succinylated
(Joyce et al., 2003; Sadovskaya et al., 2005). This modiﬁcation is
thought to be performed by themembrane localized protein, IcaC
(Atkin et al., 2014). Interestingly, a mechanism of phase variation,
where bacteria modulate virulence phenotypes at the genome
level in a rapid on/oﬀ fashion, was noted in S. aureus wherein
slipped-strand mispairing led to inactivation of icaC (Brooks and
Jeﬀerson, 2014). This phenotype confers a ﬁtness advantage that
was not seen when the ica operon was deleted, which may be a
response to modulate PIA O-succinylation and thus decrease the
overall anionic charge of the polymer.
The production of PGA has been extensively characterized
in E. coli, where the pgaABCD operon encodes the proteins
necessary for its biosynthesis (Wang et al., 2004). In E. coli,
FIGURE 5 | The PNAG and PIA modifications and biosynthetic
apparatus. Not to scale. (A) PNAG polymers are partially deacetylated by
PgaB in Escherichia coli, or IcaB in Staphylococcal species. It has been
proposed that IcaC O-succinylates the polymer in certain Staphylococcal
species, however, the location of the succinyl groups and the order of
deacetylation/succinylation has not yet been determined. The proteins involved
in PNAG biosynthesis in E. coli (B), and PIA synthesis in Staphylococcal species
(C). PNAG (blue hexagon chain) is synthesized in the cytoplasm from the
nucleotide-sugar precursor UDP-GlcNAc (blue hexagons with green inverted
triangles). The polymer is transported across the inner membrane via PgaCD,
deacetylated (light blue hexagons) by PgaB in the periplasm, and then exported
through the PgaA porin. PIA is transported across the cytoplasmic membrane
by IcaAD, then partially deacetylated by IcaB in the extracellular space. PIA has
been proposed to be O-succinylated by IcaC (magenta star).
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FIGURE 6 | Exopolysaccharide modifications of VPS and Heparosan.
(A) VPS is produced by Vibrio cholerae O1 El Tor and contains an O-acetyl
group, likely added by VpsG. In addition the polymer has a glycine modification
and an N-acetyl group; the enzymes responsible for these modifications have
not been determined. VPS contains a GulA residue which is epimerized by an
unknown C5-epimerase. (B) Heparosan, a GAG composed of a disaccharide
repeating unit of GlcA and GlcNAc, produced by select bacteria such as the
urinary tract pathogen E. coli O10:K5:H4. A C5-epimerase introduces IdoA
residues. The proteins involved in, and mechanism of, biosynthesis of the above
EPS have not been fully resolved.
approximately 3–5% of N-acetyls are removed by the lipoprotein
PgaB (Wang et al., 2004; Itoh et al., 2008; Little et al., 2012). The
N-terminal domain of PgaB is homologous to IcaB in Gram-
positive bacteria but the protein is located on the inner leaﬂet of
the outer membrane. There is no IcaC ortholog in the pgaABCD
operon, which is consistent with an observed lack of O-succinyl
groups in PGA.
Partial deacetylation of PNAG by both IcaB and PgaB is
important for a variety of bioﬁlm-associated phenotypes in
S. epidermidis, S. aureus, and E. coli. Deletion of icaB in
S. epidermidis led to the production of fully acetylated PIA,
suggesting that IcaB is not necessary for polymer production
(Vuong et al., 2004a). However, the fully acetylated polymer
was not retained at the cellular surface and was shed into the
culture media, which led to deﬁciencies in bioﬁlm formation
and surface attachment (Table 2). The lack of deacetylation
led to a loss of cationic charge in the polymer, which may
be essential for interactions with the anionic cell surface
of S. epidermidis (Vuong et al., 2004a). Furthermore, icaB-
deﬁcient mutants of S. epidermidis were more susceptible to
human cationic antimicrobial peptides and phagocytosis by
neutrophils, and were unable to persist in a mouse model
of device-related infections (Vuong et al., 2004a). Deletion of
icaB in S. aureus produced similar phenotypes (Cerca et al.,
2007). Intriguingly, the production of wall teichoic acids,
the predominant anionic component of the Gram-positive
bacterial envelope, was dispensable for adherence of PIA to
the cell surface of S. aureus (Vergara-Irigaray et al., 2008),
suggesting that other less prevalent anionic species mediate this
interaction.
In contrast to IcaB, inactivation of PgaB in E. coli prevented
polymer export, suggesting that partial deacetylation is necessary
for export through the predicted outer membrane porin PgaA
(Itoh et al., 2008). This is in line with ﬁndings that suggest
conformational changes in the C-terminal domain of PgaB, upon
binding of deacetylated PNAG, assist in targeting PNAG for
export (Little et al., 2014b). Deacetylation has also been studied
in Y. pestis, where a PNAG-like polymer is thought to mediate
bioﬁlm formation. Bioﬁlm formation in Y. pestis is crucial for
its zoonotic transmission (Jarrett et al., 2004). In the ﬂea, the
proventriculus, a feeding tube covered in spines that connects the
midgut to the esophagus, provides a platform for the adhesion
of Y. pestis aggregates. Subsequent colonization impedes blood
passage and leads to transposition of Y. pestis from ﬂea to
mammal when a ﬂea attempts excessive feeding due to a partial
or completely blocked proventriculus (Jarrett et al., 2004). The
hmsHFRS operon in Y. pestis is orthologous to the pgaABCD
operon, where HmsF is the outer membrane localized deacetylase
with structural similarity to PgaB (Forman et al., 2006). Mutation
or deletion of hmsF led to a deﬁciency in bioﬁlm formation.
This suggests HmsF in Y. pestis may be analogous to PgaB in
E. coli in terms of de-N-acetylation activity and importance for
polysaccharide export and bioﬁlm formation.
While PNAG production has been studied primarily in
S. aureus, S. epidermidis, and E. coli, there are a multitude of
additional pathogenic bacteria, fungi, and protozoans that may
produce this polymer (Cywes-Bentley et al., 2013). PNAG could
represent the ﬁrst example of an EPS that is broadly utilized by
pathogenic organisms as a mechanism to improve ﬁtness in the
environment or during infection.
Insights from Modification of Other
Microbial Polysaccharides
The implications of EPS modiﬁcations in pathogenic bacteria
have been studied to some extent, particularly in alginate and
PNAG producing bacteria (Figure 2; Table 2). However, the
breadth of our knowledge in this ﬁeld remains limited. Despite
this, comparable modiﬁcations found on LPS and CPSs have
been studied extensively in an eﬀort to identify vaccine targets,
and can be used for comparison purposes to generate new
hypotheses regarding EPS modiﬁcations (Cody et al., 2003; Pinto
and Berti, 2014). In particular, the study of polysaccharide acetyl
modiﬁcations has clariﬁed their role in mediating a variety of
survival mechanisms.
Many of the protective beneﬁts of EPS acetyl modiﬁcations
described above have been noted for other bacterial pathogens.
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For instance, in Haemophilus influenzae, an opportunistic
pathogen of the upper respiratory tract, acetylation of LPS
by the acetyltransferase OafA leads to increased resistance to
complement-mediated killing by human serum (Fox et al.,
2005). Similarly, in S. aureus, the acetyltransferase Cap5H, which
is responsible for the O-acetylation of type 5 CPS, confers
protection against opsonophagocytic killing and improves
propagation in a murine model of infection (Bhasin et al.,
1998). Type 5 CPS producers also exhibit increased survival
rates in murine models of bacteremia and renal abscess
formation and resistance to killing in whole mouse blood
and opsonophagocytic assays, in comparison to producers of
the structurally similar type 8 CPS which have reduced levels
of N-acetylation (Watts et al., 2005). Beyond the prokaryotic
domain, acetyl modiﬁcations are also incorporated into the
CPS of the pathogenic fungus Cryptococcus neoformans to
evade complement activation (Fujihara et al., 1997), decrease
the eﬃciency of capsule clearance by the host (Kozel et al.,
2003), and inhibit neutrophil migration (Ellerbroek et al., 2004)
during cryptococcosis. An excellent example of the beneﬁts of
polysaccharide acetyl modiﬁcations comes from a survey of
clinical isolates of Streptococcus pneumoniae and E. coliK1, which
found that the bacteria expressing acetyl-decorated polymers
were more virulent and invasive than those that expressed
polymers lacking the modiﬁcation (Frasa et al., 1993; Melin
et al., 2010). Therefore, the immunomodulatory characteristics
of acetyl modiﬁcations are utilized by a wide range of pathogenic
organisms and likely represent a general mechanism for survival
and proliferation within the host.
The above notion is ﬁrmly supported by studies of serotype
variation within the context of CPS biosynthesis. In Streptococcus
pneumoniae, a causative agent of meningitis, bacteremia, and
pneumonia, there are more than 90 diﬀerent capsule serotypes
with unique carbohydrate structures and biosynthetic loci.
This has evolved, in part, as a mechanism to overcome
serotype-speciﬁc host mechanisms of adaptive immunity that can
eﬃciently clear infections. In some serotypes, such as 9V/9A,
11A/11E, and 15B/15C, the CPS structures diﬀer only in the
degree of O-acetylation (Jansson et al., 1987; Rutherford et al.,
1991; Zartler et al., 2009). Mechanisms within S. pneumoniae
have been revealed that allow for serotype switching during
infection as a means to actively evade the host immune response.
In the case of serotypes 9V and 11A, inactivating mutations in the
acetyltransferase-encoding gene wceJ led to expression of non-
acetylated 9A and 11E capsule (Calix andNahm, 2010; Calix et al.,
2011). Moreover, certain wceJ mutations only partially inhibit
acetyltransferase activity, which have led to intermediate 9V/9A
and 11A/11E phenotypes (Calix et al., 2011, 2014). In the case
of 15B/15C serotype switching, the process is reversible due to
slipped-strand mispairing of the acetyltransferase-encoding gene
wciZ (van Selm et al., 2003). Regardless of the mechanism, this
mid-infection serotype variation provides signiﬁcant protective
advantages to S. pneumoniae in terms of antibody evasion. For
example, antibodies generated against O-acetylated serotype 15B
were unreactive with non-acetylated 15C polymer (Rajam et al.,
2007), and serotype 9V speciﬁc antibodies exhibited reduced
speciﬁcity for 9A polymer (Calix et al., 2012). Furthermore,
10–20% of individuals receiving a S. pneumoniae vaccine targeted
against the 9V polysaccharide did not generate antibodies
targeting serotype 9A (McNeely et al., 1998). In addition, the
ability of acetyl groups to mask protective epitopes of bacterial
polysaccharides has been noted for the Vi antigen of Salmonella
typhi (Szu et al., 1991), Salmonella typhimurium O-antigen (Kim
and Slauch, 1999) and Neisseria meningitidis serogroup A, C,
and Y CPS (Michon et al., 2000; Berry et al., 2002; Fusco et al.,
2007). Therefore, through modulation of acetyl groups on the
polymer, a wide variety of pathogenic bacteria are able to evade
host-mediated mechanisms of adaptive immunity.
The above examples illustrate scenarios in which acetyl
modiﬁcation is an all-or-nothing response to adaptive immunity,
however, in the case of GBS, acetyl levels on its sialic acid CPS
can be ﬁne-tuned by the actions of the acetyltransferase NeuD
and the acetylesterase NeuA (Lewis et al., 2006, 2007). Diﬀerent
degrees ofO-acetylation in GBS CPS have been linked to diﬀerent
stages of invasion and infection. For instance, it is thought
that during the asymptomatic stages of initial colonization and
persistence in the human gastrointestinal and vaginal tracts, GBS
produces an extensively acetylated form of CPS to protect against
degradation by sialidases introduced by competing microbes
in these environments (Weiman et al., 2009). However, highly
acetylated CPS renders GBS more susceptible to killing by
neutrophils and reduces virulence during stages of opportunistic
infections (Weiman et al., 2010). Therefore, during infection
it is thought that GBS produces a sparsely acetylated form
of CPS that improves resistance to neutrophil-mediated killing
through reduced neutrophil activation and production of pro-
inﬂammatory cytokines, and enhances survival in the murine
bladder (Kline et al., 2011). Interestingly, this variant of CPS
is also able to promote the persistence of uropathogenic E. coli
in co-culture urinary tract infection models (Kline et al.,
2012). Therefore, in certain pathogens, speciﬁc degrees of
polysaccharide acetylation allow for adaptation during diﬀerent
stages of colonization and infection.
The above examples of acetyl modulation in LPS and
CPS not only reinforce the importance of EPS acetylation
for pathogenicity and persistence, but also provide additional
perspectives in considering the variability of this modiﬁcation
observed in alginate and cepacian. For instance, cepacian has
on average three acetyl groups per repeat unit, each located on
one of 12 potential positions (Cescutti et al., 2011). Therefore,
each cepacian repeat unit can have one or more acetyl groups
at any of 12 positions, generating an overwhelming number of
unique acetyl decoration patterns. Given the importance of acetyl
groups in forming or masking antibody epitopes, this level of
diversity would make the generation of protective antibodies or
the development of an eﬀective vaccine extraordinarily diﬃcult.
Furthermore, production of such a heterogeneous polymer likely
requires an arsenal of regulatory factors and/or acetyltransferases,
very few of which have been discovered in the context of cepacian
biosynthesis (Ferreira et al., 2011). Similar to S. pneumoniae
and N. meningitidis CPS production, members of the Bcc may
modulate the presentation of cepacian acetyl groups through an
as yet unknown mechanism as a means to evade host adaptive
immune mechanisms.
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The degree of acetylation and epimerization of alginate has
long been known to diﬀer depending on the organism and
strain, as well as the composition of the growth medium (Day,
1988; Marty et al., 1992; Peña et al., 2006). This reﬂects, in
part, a need to adapt to the speciﬁc conditions imposed by
diﬀerent nutritional media, and may mirror other features of the
environment from which the organism was isolated. In line with
this concept, additional promoters within the alginate operon
have been identiﬁed upstream of algG and algIJF in P. aeruginosa,
suggesting that there may be modes of regulating the levels
of these modifying enzymes independently of the rest of the
alginate biosynthesis machinery (Paletta and Ohman, 2012). The
upregulation ofO-acetylation machinery would not only increase
alginate acetyl content, but would also decrease the availability
of substrate for AlgG and thus decrease epimerization levels.
Conversely, upregulation of algG would increase the number
of G-residues that cannot act as substrates for O-acetylation.
Therefore, there is the potential for a complicated regulatory
interplay between these processes, much like the reciprocal
O-acetylation/de-O-acetylation of GBS CPS that allows for ﬁne-
tuning of acetyl levels at diﬀerent stages of infection.
The degree of PNAG de-N-acetylation is not known to vary
considerably, and the exact processes involved in VPS acetylation
and epimerization, PIA O-succinylation, PEL deacetylation
and GAG epimerization are poorly understood. However, the
ability to perform these types of modiﬁcations in a random
fashion may increase the diﬃculty in generating antibodies
that recognize speciﬁc epitopes on these EPS, either during
host adaptive immune responses or in vaccine development
(Gening et al., 2010). As such, EPS modiﬁcations are capable of
imparting beneﬁcial characteristics upon polymers that improve
persistence, survival, or evasion of the immune response in their
cognate bacteria regardless of their frequency, mechanism of
addition to the polymer, or chemical properties.
Reflection and Future Perspectives
Identifying and characterizing bioﬁlm EPS is diﬃcult and
there are a number of hurdles that need to be overcome.
One of the initial challenges involves culturing bioﬁlm-forming
bacteria. Identiﬁcation of an appropriate medium and growth
conditions is required to study EPS production of certain
microorganisms in the laboratory (Stewart, 2012). Of those
that can be cultured, it is imperative to use similar growth
conditions when making experimental comparisons in the
literature, as variations can aﬀect the presence or degree of
diﬀerent polysaccharide modiﬁcations. With alginate, varying
levels of acetylation and epimerization are observed depending
on the culture conditions, as well as varying bioﬁlm phenotypes
of identical P. aeruginosa strains (Pier et al., 2001; Tielen et al.,
2005). Additionally, conﬂicting studies on the levels of pyruvyl
and O-acetyl modiﬁcations to xanthan gum were attributed to
diﬀerent media conditions (Bradshaw et al., 1983). Diﬀerent
media or culturing equipment may also aﬀect experiments such
as surface attachment assays. For example, diﬀerent types of
plastics were found to aﬀect PIA-mediated surface attachment
in microtitre plates (Maira-Litràn et al., 2004). This suggests
that during preliminary analyses, multiple types of media and
diﬀerent materials including plastics and glass should be tested to
ensure the validity of observed bioﬁlm phenotypes. Variations in
the abundance or type of modiﬁcations on a given polymer under
diﬀerent experimental conditions can be diﬃcult to quantify;
however, this variation likely reﬂects the ability of diﬀerent
bacteria to adapt to unique situations. Many EPS-producing
bacteria naturally exist in diverse environments and are also
able to infect various hosts and survive in speciﬁc tissues.
Additionally, during the course of infection, the environment
within the host will change as immune mechanisms attempt to
eradicate the bacteria and the surrounding tissue suﬀers damage.
Variations in the degree of modiﬁcations under diﬀerent growth
conditions or stressors may therefore provide valuable insight
into bacterial adaptation.
The majority of bioﬁlm studies focusing on EPS modiﬁcations
have been performed using in vitro model systems with mono-
species cultures. However, the majority of bioﬁlms from chronic
infections diﬀer signiﬁcantly from those studied in the laboratory
(Bjarnsholt et al., 2013a). One signiﬁcant issue lies in the use of
abiotic surfaces, such as cover slides or the plastic surfaces of
96-well plates for the growth and study of bioﬁlms. While some
systems can closely approximate the conditions encountered in
vivo, such as ﬂow cell models for catheter associated infections,
bioﬁlms from infections like CF pneumonia or those encountered
in epidermal wounds are thought to involve attachment to host
cells or host-derived molecules (Bjarnsholt et al., 2009). In these
instances it is challenging to extrapolate results obtained in
vitro to chronic bioﬁlm infections, as modiﬁcations that appear
important for attachment to abiotic surfaces may be disposable
for attachment to host tissues, or vice versa (Leuck et al., 2014).
Furthermore, many bioﬁlms encountered in the clinic are not
comprised of a single species of bacteria, but rather contain
mixtures that can include pathogenic or non-pathogenic bacteria
of host or environmental origin, as well as fungi (Wargo and
Hogan, 2006; Elias and Banin, 2012). These types of microbial
interactions have been studied extensively in the CF lung,
where P. aeruginosa has been shown to interact with the Bcc
opportunistic pathogens B. cepacia and B. cenocepacia (Chattoraj
et al., 2010; Schwab et al., 2014), as well as the pathogenic
fungus Aspergillus fumigatus (Chotirmall and McElvaney, 2014).
In the case of mixed P. aeruginosa and B. cenocepacia bioﬁlms,
the production of alginate by P. aeruginosa has been shown
to promote B. cenocepacia persistence in a mouse model of
CF (Chattoraj et al., 2010). This highlights how the production
of EPS in mixed species bioﬁlms can have implications that
extend beyond the source organism, and suggests that data
obtained regarding the presence or absence of EPS modiﬁcations
in monospecies bioﬁlms in vitromay have additional signiﬁcance
in multispecies bioﬁlms.
Following bacterial culturing, diﬃculties in polysaccharide
isolation due to the compositional complexity of the bioﬁlm
matrix or polymer insolubility may necessitate extensive
optimization of puriﬁcation protocols. Typically, separation
of the polymer from the cell surface may require the use
of procedures that lyse the associated bacteria, introducing
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additional contaminants (Bales et al., 2013). Therefore, it is
preferable if possible to isolate EPS from culture supernatants;
however, such polymers may exhibit diﬀerent properties from
their cell-associated counterparts leading to discrepant analysis
(Maira-Litràn et al., 2002). In either case, once the polymer has
been obtained from the cell surface or supernatant, contaminants
such as DNA, RNA and protein must be removed. This can be
achieved through enzymatic digestion or chemical precipitation
of contaminants, or precipitation of EPS. Contaminating
carbohydrates can be removed by chromatographic techniques
such as size exclusion or ion exchange (Bales et al., 2013).
In some cases, puriﬁcation of EPS leads to insuﬃcient yields
for subsequent compositional or structural analysis, often as a
result of polymer insolubility. As a result, harsher conditions
may need to be employed to solubilize the polymer, including
the use of strong acids or bases. During initial structural
studies of PIA, strong alkaline puriﬁcation conditions led to the
incorrect identiﬁcation of N-succinyl groups on the polymer
(McKenney et al., 1999; Maira-Litràn et al., 2002), which was
actually a degradation product of glucosamine monosaccharides
(Sadovskaya et al., 2005). Additionally, phosphates have been
reported in the monosaccharide composition of polymers, which
are occasionally remnants from puriﬁcation buﬀers, or teichoic
acids in the case of Gram-positive bacteria (Sadovskaya et al.,
2005). Harsher conditions can also partially or completely
remove functional groups, such as acetyls, or even degrade
the polymer, leading to incorrect calculations of molecular
weight. The EPS described in this review are the select few
whose structures have been determined, or for which we have
biochemical and genetic data supporting the importance of
the polysaccharide modiﬁcations. With improved culturing,
puriﬁcation and structural determination procedures, additional
EPS will be discovered and their modiﬁcations characterized.
We will then be able to formulate trends between diﬀerent
types of modiﬁcations and their eﬀect on bioﬁlm formation,
pathogenicity, and virulence. Furthermore, the details regarding
the genes and proteins involved in the addition of polysaccharide
modiﬁcations remain largely unavailable. Characterization of
these genes and proteins will likely provide details on how the
levels and types of modiﬁcations are regulated under diﬀerent
conditions. Such ﬁndings will have a signiﬁcant impact on
our understanding of bacterial pathogenicity, and may reveal
novel drug targets aimed at inhibiting the biosynthesis of these
important virulence factors.
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